Thank you, Sameer. Good afternoon and thank you for joining us for our first quarter 2020 conference call. These are unprecedented times and I hope that all of you and your loved ones are safe and healthy. The three of us that Sameer, Todd and myself are in our respective homes for this earnings call. I'll begin with an update on how COVID-19 has impacted our business, followed by a review of our business strategy, including highlights from the quarter and by a discussion of our first quarter results. Todd Schull, our CFO will follow with an overview of our Q1 2020 financial performance and our Q2 2020 guidance. We will then open the call to your questions. I am pleased to report that in the first quarter of 2020, TTM generated revenues above the midpoint and non-GAAP EPS above the guided range, despite the extended shut down of our China operations following Chinese New Year, as our manufacturing plants did a great job of ramping up production following the government mandated shutdown. In addition, North American governments have deemed TTM products as essential and all of our manufacturing plants are presently operating as we supply defense programs, communications infrastructure, and medical products. The emergence of the COVID-19 pandemic has created operational challenges, macroeconomic uncertainty, and employee concerns. I am extremely proud of how TTM employees have risen to the challenge and contributed during the pandemic. At the end of 2019, TTM had more than 25,000 employees, with the majority of them split between North America and Asia Pacific. Since the earliest signs of the outbreak in China, we immediately established an Asia based situational leadership team to organize proactive measures to safeguard our employees. After the virus spread to North America, we implemented best practices from our Asia-Pacific facilities in our North American facilities. Such practices include where possible TTM employees work from home. We have restricted all local and international business travel globally and we have implemented a regimen in our facilities to protect our employees from the spread of the disease through procedures such as regular facility sterilization, mandatory masks in our facilities, temperature checks for all incoming employees and visitors, mandatory quarantine for employees returning from the impacted areas and other measures. Our Asia team even began producing masks in order to contribute to the safety of our facilities and employees worldwide. As of yesterday, we have had 10 employees in North America, who have tested positive for COVID-19 and are receiving appropriate medical attention. In each of these cases, our North America situational leadership team responded immediately using contact tracing the quarantine individuals who are in close contact with the infected team member, also by sterilizing the area in which they work and by alerting our workforce at the six sites involved on all shifts to review measures that have been taken. As a result of stringent preventative measures in place, these events have had minimal impact on our manufacturing operations to date. At this time, we have had zero cases in our Asia-Pacific facilities. In terms of communications, we have established a task for us at the corporate level to coordinate communications with our customers and employees. For our employees, we provide biweekly email updates. I hosted by monthly town hall and we have daily contacts from our human resources personnel to each employee, who is absent from a plant on any given day, so that we can provide the right level of assurance and transparency to our employees. I would like to recognize the extraordinary efforts of our situation leadership teams, operations management, and human resources organization in these efforts. In the second quarter, we have also implemented an incentive bonus as a means of thanking our employees who continue to come to work at our plants. In addition, we are granting one week of paid time off for each employee, who needs to be out of the office due to exposure to COVID or family member who has been exposed to COVID or an employee who has been exhibiting flu like symptoms. We also have established a PTO bank where employees can grant their unused PTO to those who are in need of additional PTO for COVID reasons. We feel that these are the right measures for TTM to take to recognize the sacrifice of our employees and to put the safety of our employees first. Moving onto the Mobility divestiture. 10 days ago, we announced that we closed the previously reported divestiture of our Mobility business unit to AKMMeadville, a Chinese consortium for an enterprise value of $645 million. This was a strategic transaction allowing us to focus on longer cycle markets and reducing our exposure to short product cycle and seasonal consumer markets, which historically have been prone to volatility. The consideration was $550 million for four China manufacturing facilities and did not include certain accounts receivable of approximately $95 million. Accounts receivable were lower than previously disclosed due to an earlier than expected closing of the transaction. We felt that the surety of closing during a period of macroeconomic uncertainty outweighed the lower accounts receivable. Net proceeds are expected to be $580 million, which we plan to use to reduce debt and invest in the company. The receipt of proceeds will take another three to four months as we follow protocols related to transferring funds out of China. In addition, we have bank guarantees that we can exercise to receive U.S. dollars, if we do not receive funds by August 7. This transaction aligns with our strategic focus on diversification, differentiation and discipline, and we expect that in the long term, it will pay off for TTM, our investors and our customers. Finally, we just issued a press release that discusses the restructuring of our E-MS business unit. The E-MS business unit consists of three Chinese manufacturing facilities with two being in Shanghai backplane and Shanghai E-M Solutions and one in Shenzhen. TTM will be ceasing operations at the Shanghai E-M Solutions and Shenzhen facilities, while leaving the Shanghai backplane facility, operating and absorbing it into our PCB operations. The complete wind down will take place through 2020, as we support our customers during their transition to other suppliers. For 2019, the Shenzhen and Shanghai E-M Solutions plants had $161.2 million in revenue and $9.5 million in non-GAAP operating income, primarily in the automotive, networking, and communications and medical, industrial and instrumentation end markets. The strategic rationale for this move is based on TTMs increasing focus on differentiated higher margin products such as PCBs, and RF components and sub-assemblies. Commercial assembly services have always been a lower margin business. The following particular factors led to this decision. Number one, the recent trade tensions between the U.S. and China, it had a negative impact on the E-MS business as much of our product was imported directly by our customers into the U.S. Number two, the E-MS business has further weekend following the disruptions of the supply chain and the end market demand by the COVID-19 virus. Number three, the town of Nan Xiang in the JiaDing Red District of Shanghai has advised us of their intent to expropriate the land Shanghai E-MS occupies. This area is earmarked for other non-industrial uses. Number four, the business did not have sufficient scale to adequately compete with larger competitors with global manufacturing footprints. Number five, the business had lower profit margins and returns then TTM's core PCB business. And finally, the transaction also does reduce our China footprint, which is another positive given continued trade friction between the US and China. We are determined to make the transition as painless as possible for our customers, but this was a decision that needed to be made for strategic, as well as financial reasons. Now, I'd like to review our end markets. All historical reported end market disclosures continue to include the Mobility business unit. Our forecast for Q2 includes results of the Mobility business unit, up to the closing date of the sale. The end market disclosures still contain all of the E-MS segment revenues. For pro forma comparisons excluding these segments, please refer to the appendix of our Investor Presentation posted to our website. For TTM, the aerospace and defense end-market represented 30% of total first quarter sales compared to 27% of Q1 2019 sales and 26% of sales in Q4 2019. We expect sales in Q2 from this end market to represent about 34% of our total sales. We continue to see solid growth in our A&D business, with Q1 revenues up 12% year-on-year and A&D program backlog growing to $612 million, compared to $487 million in the year ago quarter. Ongoing strength as a result of our strong program alignment and a key new booking for the LTAMDS program, which stands for Lower Tier Air and Missile Defense system and is an upgrade of Raytheon's Patriot Missile Program. The medical industrial instrumentation end market contributed 16% of our total sales in the first quarter, compared to 15% in the year ago quarter and 13% in the fourth quarter of 2019. We saw strength in our instrumentation customers that was offset by weakness in our industrial customers in our E-MS segment. For the second quarter, we expect this market to be 18% of revenues, due primarily to increase demand for medical equipment such as patient monitoring devices and ventilators. Networking communications accounted for 14% of revenue during the first quarter of 2020. This compares to 18% in the first quarter of 2019 and 15% of revenue in the fourth quarter of 2019. Year-on-year growth for PCBs for Chinese 5G base stations was more than offset by declines in networking customers, networking and telecom customers in our E-MS segment, and U.S. made wireless components sold to Huawei, which were impacted by the trade conflict. Sales were also impacted by production limitations due to the extended shut down of production at our China facilities as a result of COVID-19. In Q2, we expect this segment to be 18% of revenue as demand for 5G infrastructure and networking equipment increases. Sales in the computing storage peripherals end market represented 14% of total sales in the first quarter, compared to 13% in Q1 of 2019 and 14% in the fourth quarter of 2019. We saw strength in our semiconductor and data center customers. The laptop and tablet revenues were approximately 26% of computing revenues in Q1 and are included in the mobility business unit divestiture. We expect revenues in this end market to represent approximately 13% of second quarter sales, as only three weeks of laptop and tablet sales are included. Automotive sales represented 12% of total sales during the first quarter of 2020, compared to 17% in the year ago quarter and 14% during the fourth quarter of 2020. Automotive sales declined year-over-year due to reduced production days resulting from the government mandated shut down in China, as well as demand weakness, particularly in Europe and China. Approximately 36% of the year-on-year decline was due to weakness in the E-MS segment. We expect automotive to contribute 13% of total sales in Q2 with ongoing global weakness in demand is expected. The cellular phone end market accounted for 11% of revenue in the first quarter, compared to 7% in Q1 of 2019 and 16% in Q4 of 2019. We expect cellular to represent 2% of revenues in Q2 as only three weeks of mobility revenues are included. Next, I'll cover some details from the first quarter. During the quarter, our advanced technology business, which includes HDI, rigid-flex, substrate, and RF subsystems and components accounted for approximately 39% of our company's revenue. This compares to approximately 33% in the year ago quarter and 42% in Q4. The sequential and year-over-year changes were due to combined effects in our cellular and computing end markets. We are continuing to pursue new business opportunities and increase customer design engagement activities that will leverage our advanced technology capabilities in new markets. Capacity utilization in Asia Pacific was 47% in Q1, due largely to the impact of the extended Chinese New Year shutdown and slow recovery period during February, compared to 55% in the year ago quarter and 72% in Q4. Our overall capacity utilization in North America was 67% in Q1, compared to 62% in the year ago quarter and 58% in Q4. Our top five customers contributed 34% of total sales in the first quarter of 2020 compared to 29% in the year ago quarter and 37% in the fourth quarter of 2019. Our largest customer accounted for 13% of sales in the first quarter versus 9% in the year ago quarter and 18% in Q4. At the end of Q1, our 90-day backlog, which is subject to cancellations was $587.4 million, compared to $438.3 million at the end of the first quarter last year and $511.2 million at the end of Q4. Our PCB book-to-bill ratio was 1.15 for the three months ending March 30. I'd like to conclude by again thanking our employees for continuing to contribute to TTM and our critical mission of inspiring innovation for our customers. Their efforts are particularly appreciated during these times by our customers in the medical industry. While we are facing short-term uncertainty from COVID-19, we are taking the right strategic moves to strengthen TTM for the long term. Now, Todd will review our financial performance for the first quarter. Todd?